Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single-arm, Multicenter, Efficacy and Safety Study to Investigate Batten-1 (Miglustat Oral Liquid Formulation) for the Treatment of Pediatric Subjects With CLN3 Disease

NCT07882290 is registered in ClinicalTrials.gov with Beyond Batten Disease Foundation as lead sponsor.

NCT NCT07882290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07882290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single-arm, Multicenter, Efficacy and Safety Study to Investigate Batten-1 (Miglustat Oral Liquid Formulation) for the Treatment of Pediatric Subjects With CLN3 Disease
Lead sponsor
Beyond Batten Disease Foundation
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
June 30, 2028
Enrollment
27 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cln3